Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear Cells
Clinical trial NCT01414634 · COMPLETED
Trial details
- NCT number
- NCT01414634
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2012-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.